Email alerts
Advanced Search
  • Jan 17, 2014
    Medtronic CoreValve® System Obtains Early FDA Approval on Exceptional Clinical Performance
    Self-Expanding Aortic Valve Serves Broad Spectrum of Potential Transcatheter Aortic Valve Replacement (TAVR) Patients Who Are Unable to Undergo Surgery

    MINNEAPOLIS - Jan. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for severe...

  • Jan 16, 2014
    Covidien Declares Quarterly Cash Dividend

    DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

  • Jan 15, 2014
    Medtronic to Appeal Federal District Court Verdict

    MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...

  • Jan 15, 2014
    Covidien Completes Sale of Confluent Surgical to Integra LifeSciences

    DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

  • Jan 14, 2014
    HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
    Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012

    HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

Show 5102550100 per page